Examedi

High-Level Overview

Examedi is a Chilean healthtech startup that operates as an "Uber for Healthcare" in Latin America, providing an on-demand marketplace where patients can book lab tests and other medical services to be performed at home by nurses and technicians. Its platform simplifies healthcare access by bringing services such as COVID-19 tests, blood tests, STI testing, vaccinations, and kinesiology sessions directly to patients’ homes, primarily serving urban centers like Santiago and Mexico City. Examedi addresses inefficiencies and high costs in traditional lab testing by offering faster, more affordable, and convenient healthcare delivery, with prices up to 80% cheaper than competitors. The company is actively expanding across Latin America, targeting Colombia and Peru, and plans to introduce subscription models and partnerships with pharmacies to bundle medications and tests for chronic patients like those with diabetes[1][2][3].

Origin Story

Founded in 2021 by Chilean entrepreneurs including Andres Kemeny and Juan Pablo Zepeda, Examedi emerged from the founders’ backgrounds in software engineering and industrial engineering with logistics expertise. The idea was inspired by the success of ride-hailing apps like Uber, aiming to "uberize" healthcare logistics to improve patient access and reduce healthcare inequality in Latin America. Early traction included rapid adoption in Chile and Mexico, supported by participation in Y Combinator’s Summer 2021 batch and a $17 million Series A funding round led by General Catalyst. The founders leveraged their experience managing large-scale logistics operations to build a platform that matches patients with healthcare professionals efficiently[2][3][6].

Core Differentiators

• Product Differentiators: Examedi offers a seamless digital platform that enables patients to schedule and receive medical tests and services at home without the need for clinic visits or doctor referrals. It covers a broad range of services beyond lab tests, including wellness and rehabilitation[1][5].

- Developer Experience: The platform integrates logistics and healthcare workflows to optimize scheduling and service delivery, allowing nurses to choose their visits and work flexibly[1][2].

• Speed, Pricing, Ease of Use: The entire testing process takes about 10 minutes, is significantly cheaper (up to 80% less), and eliminates waiting lines and multiple touchpoints typical in traditional lab testing[1][3][6].

• Community Ecosystem: Examedi is building partnerships with pharmacies and healthcare providers to create bundled offerings and subscription models, aiming to become a comprehensive healthcare partner for Latin American families[1][3].

Role in the Broader Tech Landscape

Examedi rides the global trend of healthcare digitization and decentralization, particularly the shift toward at-home care accelerated by the COVID-19 pandemic. Latin America’s healthcare system, characterized by high out-of-pocket expenses and limited access to efficient lab testing, creates a strong market need for Examedi’s model. The timing is favorable due to increasing smartphone penetration, urbanization, and demand for convenient healthcare solutions. By leveraging e-commerce and ride-hailing logistics models, Examedi is transforming patient engagement and healthcare delivery in the region, potentially reducing healthcare inequality and improving outcomes[1][3][6].

Quick Take & Future Outlook

Examedi is poised for steady growth and regional expansion, focusing on profitable scaling in Mexico and Chile while entering new markets like Colombia and Peru. Future trends shaping its journey include the rise of telehealth, integrated healthcare services, and consumer demand for personalized, convenient care. The company’s move toward subscription models and wellness apps signals a broader ambition to become a daily healthcare partner rather than a one-off service provider. Examedi’s influence is likely to grow as it integrates more stakeholders in the healthcare ecosystem, driving innovation and accessibility in Latin America’s healthtech landscape[1][3][5][4].